Breaking News

Spero Therapeutics Inc (SPRO)

NASDAQ

Add to/Remove from a Portfolio Add to Watchlist

2.020 -0.130 -6.04%

15:30:16 - Real-time Cboe. Currency in USD

Type: Equity

Market: United States

Volume: 295,690
Bid/Ask: 0.000 / 0.000
Day's Range: 1.860 - 2.180

General
Chart
- Streaming charts
- Interactive Chart
News & Analysis
- News
- Analysis & Comment
Financials
Technical
Forum

Spero Therapeutics Inc Company Profile

Get an in-depth profile of Spero Therapeutics Inc, including a general overview of the company's business and key management, as well as employee data and location and contact information.

IndustryBiotechnology & Medical Research

SectorHealthcare

Employees

Equity Type

ORD

Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying and developing novel treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States. The company’s product candidates include Tebipenem HBr (tebipenem pivoxil hydrobromide), an oral carbapenem-class antibiotic to treat complicated urinary tract infections, including pyelonephritis for adult patients, which is in Phase 3 development; and SPR720, a novel product candidate for first-line treatment of nontuberculous mycobacterial (NTM) pulmonary disease. It has license agreement with Meiji Seika Pharma Co., Ltd. to support the development of tebipenem HBr; Everest Medicines to develop, manufacture, and commercialize SPR206 in Greater China, South Korea, and Southeast Asian countries; and Vertex Pharmaceuticals Incorporated for patents relating to the oral prodrug SPR720, as well as SPR719, an active metabolite. Spero Therapeutics, Inc. was founded in 2013 and is headquartered in Cambridge, Massachusetts.

Contact Information

Address 675 Massachusetts Avenue 14th Floor
Cambridge, 02139
United States

Phone (857) 242-1600

Fax -

Web sperotherapeutics.com

Top Executives

Name	Age	Since	Title
Frank Edward Thomas	56	2017	Independent Chairman
Milind S. Deshpande	68	2014	Independent Director
Gordon L. Archer	81	2014	Clinical Advisor
Jeffrey L. Stein	70	-	Scientific Advisor
Paul G. Ambrose	-	2014	Clinical Advisor
John C. Pottage	72	2018	Independent Director
Steven C. Gilman	72	-	Scientific Advisor
George L. Drusano	-	2014	Clinical Advisor
Helen W. Boucher	-	-	Clinical Advisor
Kathleen Tregoning	54	2021	Independent Director
Ankit Mahadevia	44	2013	Co-Founder & Director
David Livermore	-	-	Scientific Advisor
James B. Kahn	-	-	Clinical Advisor
Eric M. Gordon	-	2014	Scientific Advisors
Esther P. Rajavelu	46	2023	CEO, CFO, President, Treasurer & Director
Paul Francis Miller	64	-	Scientific Advisor
Patrick V. J. J. Vink	62	2015	Lead Independent Director
Keith A. Rodvold	-	-	Clinical Advisor
Martti Vaara	-	-	Scientific Advisor
Richard C. White	-	-	Scientific Advisor
William Hope	-	-	Clinical Advisor
Scott T. Jackson	60	2020	Independent Director
Cynthia Smith	56	2019	Independent Director

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:

Enrich the conversation
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically.
Use standard writing style. Include punctuation and upper and lower cases.
NOTE: Spam and/or promotional messages and links within a comment will be removed
Avoid profanity, slander or personal attacks directed at an author or another user.
Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I have read and understood Investing.com Nigeria's comment guidelines and agree to the terms described.

I Agree

SPRO Comments

Write your thoughts about Spero Therapeutics Inc

Are you sure you want to delete this chart?

Delete Cancel

Post

Post also to:

Replace the attached chart with a new chart ?

Replace Cancel

1000

Comment Guidelines

Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.

Please wait a minute before you try to comment again.

Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.

<div id="comment">
				<div class="comment js-comment" data-comment-id="{commentID}" id="comment-{commentID}" data-user-id="">
    <div class="mainComment js-content">
       <div class="commentInnerWrapper">
        <a href="{userLink}" class="js-user-link"><img src="{userImage}" width="33" height="33" alt="{usernameAlt}" class="img" onerror="this.src='https://i-invdn-com.investing.com/defaultUserMaleTmp.png';"></a><div class="commentBody">
                					<span class="commentUsername">
                    	<a href="{userLink}" class="js-user-link js-user-name">{username}</a>
					</span>
                                <span class="js-date" comment-date="{dateFormat}" comment-date-formatted="{dateFormatted}" title="{dateTitle}">Just Now</span>
                <div class="commentDropDown js-commentDropDownWrapper " data-user-id="" data-cid="{commentID}">
	<a href="javascript:void(0);" class="threeDotsIconSmall js-thinDropdownArrow"></a>
	<div class="tooltipPopup commentActionsPop noHeader js-commentDropDownOptions displayNone">
		<div class="addRow js-option share">
			<a href="javascript:void(0);" class="js-commentSharePopup" data-cid="{commentID}" data-curl="{commentLink}"><span class="smallShareIcon middle"></span>Share</a>
		</div>

<div class="js-option addRow follow">
            <div class="js-follow-post-button" data-reg_ep="follow comment">
                <span class="alertfollowIcon middle"></span>Follow this post            </div>
            <div class="js-unfollow-post-button displayNoneImp">
                <span class="alertUnfollowIcon middle"></span>Unfollow this post            </div>
        </div>

<div class="addRow js-option save"  data-reg_ep="save comment">
		<a href="javascript:void(0);" class="js-save-item-btn" data-item-type="comments" data-item-id="{commentID}">
			<i class="saveItemBigIcon middle"></i>
			Save		</a>
	</div>
	<div class="addRow saveItemsConfirmation noHover displayNone js-saveItemResult">
		
<div class="content js-saveItemSuccess displayNone">
	<span class="mediumGreenSuccessIcon"></span><span>Saved. See <a href="/members-admin/saved-items" target="_blank">Saved Items</a>.</span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
<div class="content js-saveItemAlreadySaved saveItemAlreadySaved displayNoneImp">
	<span>This comment has already been saved in your <a href="/members-admin/saved-items" target="_blank">Saved Items</a></span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
	</div>

<div class="addRow shareButtons js-sharePopup displayNone">
			<div class="js-shareComment"><span class="js-shareCommentSpan"></span></div>
		</div>
	</div>
</div>
                 <div class="commentAuthor js-comment-by-author"><span class="commentAuthorIcon"></span>Author's response</div>             </div>
		<div id="commentText-{commentID}" class="js-text-wrapper commentText withImage">
							<div id="commentBigChart{commentID}" class="commentBigChart js-comment-chart" onclick="openViewChartPopup('{commentID}')">
					<img src="https://d72-invdn-com.investing.com/comments_images/{commentImage}" alt="{commentAlt}">
					<i class="newMagnifyChartIcon"></i>
				</div>
						<span class="js-text">{commentContent}</span>
			<div class="clear"></div>
							<div class="commentButtons js-not-master-user">
					<a href="javascript:void(0)" class="reply js-reply-btn" data-real-parent-id="{commentID}" data-to-user-name="{username}" data-to-user-id="">Reply</a>
					<div class="inlineblock likeDislikeBox js-like-dislike-box" data-item-id="{commentID}">
	<input class="js-like-checkbox" type="checkbox" name="option" value="Yes" id="like_{commentID}">
	<label for="like_{commentID}" class="like" title="I agree"></label>
	<span class="numOfLikes js-like-count lighterGrayFont">0</span>
	<input class="js-dislike-checkbox" type="checkbox" name="option" value="No" id="dislike_{commentID}">
	<label for="dislike_{commentID}" class="dislike" title="I disagree"></label>
	<span class="numOfDislikes js-dislike-count lighterGrayFont">0</span>
</div>

<div class="reportComment js-flag float_lang_base_2">
                            <a href="javascript:void(0);" id="commentFlag_{commentID}">
                                <span class="reportCommentIcon middle"></span><span class="inlineblock middle">Report</span>
                            </a>
                        </div>
                    				</div>
					</div>
	   </div>
	</div>
	</div>			</div>
			<div id="reply">
				
    <div class="commentReply js-comment js-comment-reply" data-comment-id="{commentID}" id="comment-{commentID}" data-user-id="">
		<div class="commentInnerWrapper"><a href="{userLink}" class="js-user-link"><img src="{userImage}" width="33" height="33" alt="{usernameAlt}" class="img" onerror="this.src='https://i-invdn-com.investing.com/defaultUserMaleTmp.png';"></a><div class="commentBody js-content">
            				<span class="commentUsername">
					<a href="{userLink}" class="commentUsername js-user-link js-user-name" onMouseOver="">{username}</a>
				</span>
                        <span class="js-date" comment-date="{dateFormat}" comment-date-formatted="{dateFormatted}" title="{dateTitle}">Just Now</span>
			 <div class="commentAuthor js-comment-by-author"><span class="commentAuthorIcon"></span>Author's response</div> 			<div class="commentDropDown js-commentDropDownWrapper " data-user-id="" data-cid="{commentID}">
	<a href="javascript:void(0);" class="threeDotsIconSmall js-thinDropdownArrow"></a>
	<div class="tooltipPopup commentActionsPop noHeader js-commentDropDownOptions displayNone">
		<div class="addRow js-option share">
			<a href="javascript:void(0);" class="js-commentSharePopup" data-cid="{commentID}" data-curl="{commentLink}"><span class="smallShareIcon middle"></span>Share</a>
		</div>

</div>
		<div id="commentText-{commentID}" class="js-text-wrapper commentText withImage">
							<div id="commentBigChart{commentID}" class="replyBigChart displayNone js-comment-chart">
					<img src="https://d72-invdn-com.investing.com/comments_images/{commentImage}" alt="{commentAlt}">
					<i class="newMagnifyChartIcon"></i>
				</div>
				<span id="commentSmallChart{commentID}" class="commentSmallChart pointer js-comment-chart" onclick="openViewChartPopup('{commentID}')">
                    <img src="https://d72-invdn-com.investing.com/comments_images/{commentImageSmall}" width="116" height="52" alt="{commentAlt}">
                    <span class="chartMagnifyOverlay displayNone"></span>
                    <span class="searchGlassIcon chartMagnify displayNone"></span>
                </span>
						<span class="js-text">{commentContent}</span>
			<div class="clear"></div>
							<div class="commentButtons js-not-master-user">
					<a href="javascript:void(0)" class="reply js-reply-btn" data-real-parent-id="{commentID}" data-to-user-name="{username}" data-to-user-id="">Reply</a>
					<div class="inlineblock likeDislikeBox js-like-dislike-box" data-item-id="{commentID}">
	<input class="js-like-checkbox" type="checkbox" name="option" value="Yes" id="like_{commentID}">
	<label for="like_{commentID}" class="like" title="I agree"></label>
	<span class="numOfLikes js-like-count lighterGrayFont">0</span>
	<input class="js-dislike-checkbox" type="checkbox" name="option" value="No" id="dislike_{commentID}">
	<label for="dislike_{commentID}" class="dislike" title="I disagree"></label>
	<span class="numOfDislikes js-dislike-count lighterGrayFont">0</span>
</div>

Are you sure you want to delete this chart?

Delete Cancel

Post

Replace the attached chart with a new chart ?

Replace Cancel

1000

Comment Guidelines

Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.

Please wait a minute before you try to comment again.

I feel that this comment is:

Spam

Offensive

Thank You!

Your report has been sent to our moderators for review

More Categories

1D1W1M6M1Y5YMax

NSE 30	5,082.13	+5.37	+0.11%
NSE All Share	139,394.75	+414.74	+0.30%
US 30	45,403.5	+2.4	+0.01%
US 500	6,500.6	+19.1	+0.29%
FTSE 100	9,197.07	-11.14	-0.12%
DAX	23,758.81	+167.18	+0.71%
South Africa Top 40	95,259.17	+1093.54	+1.16%

Brent Oil	65.91	+0.41	+0.63%
Crude Oil WTI	62.16	+0.29	+0.47%
Gold	3,669.72	+16.42	+0.45%
Silver	41.845	+0.293	+0.71%
Copper	4.5615	+0.0105	+0.23%
London Cocoa	5,121.00	-32.00	-0.62%
London Wheat	166.10	+0.20	+0.12%

Nigeria 10Y	16.625	0.000	0.00%
Nigeria 2Y	17.572	+0.000	+0.00%
U.K. 10Y	4.6110	-0.0390	-0.84%
Germany 10Y	2.6404	-0.0176	-0.66%
U.S. 10Y	4.049	-0.033	-0.81%
U.S. 5Y	3.563	-0.020	-0.56%
U.S. 2Y	3.484	-0.023	-0.66%

Fidelitybk	20.400	-0.600	-2.86%
Zenith Bank	65.75	+0.85	+1.31%
UBA	46.75	0.00	0.00%
First HoldCo	30.50	-1.80	-5.57%
Guaranty Trust Holding	92.00	0.00	0.00%
Sterling Bank	7.500	0.000	0.00%
Dangote Cement	520.20	0.00	0.00%

Recent Quotes

Name	Price	Chg.	Chg. %
SPRO	2.020	-0.130	-6.04%
MTS Italy BOT Ex .	324.23	+0.12	+0.04%
VIE	28.48	+0.05	+0.18%
Landkreditt Høyre.	106.811	+0.045	+0.04%
FUNDO DE INVESTIM.	4.577	+0.002	+0.04%
China Southern Li.	1.721	+0.012	+0.73%
FTSC	4,760	+45	+0.95%
XIRN	0.600	0.000	0.00%

Market Movers

Name	Last	Chg. %	Vol.
Fcmb	10.500	0.00%	460.95M
Zenith Bank	65.75	+1.31%	26.73M
First HoldCo	30.50	-5.57%	25.91M
Dangote Sugar	60.00	+9.09%	23.59M
Guaranty Trust Holding	92.00	0.00%	17.41M
Transcorp Power	314.00	+9.60%	2.50M
Nestle Nigeria	1,870.00	0.00%	524.12K

Name	Last	Chg. %	Vol.
PZ Cussons Nigeria	35.20	+10.00%	6.53M
University Pre	5.500	+10.00%	608.04K
Ellah Lakes	14.27	+9.94%	20.22M
Ncr Nigeria	13.95	+9.84%	545.78K
Aiico	3.83	+9.74%	25.45M
Etranz	11.300	+9.71%	3.84M
Transcorp Power	314.00	+9.60%	2.50M

Name	Last	Chg. %	Vol.
Union Dicon Salt	10.80	-10.00%	626.67K
Thomaswy	2.70	-10.00%	5.07M
Industrial Medical Gases Nigeria	33.30	-10.00%	109.50K
Nigerian Enamelware PLC	35.10	-10.00%	253.90K
Academy Press	8.60	-9.95%	600.68K
Eternaoil	31.00	-9.36%	279.38K
Transcorp	46.050	-7.34%	1.43M